Nalaganje...

Sodium glucose transporter 2 (SGLT2) inhibition and ketogenesis

Sodium glucose transporter 2 (SGLT2) inhibitors are a recently developed class of drug that have been approved for use in type 2 diabetes. Their unique extra-pancreatic glucuretic mode of action has encouraged their usage in type 1 diabetes as well. At the same time, reports of pseudo ketoacidosis a...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Indian J Endocrinol Metab
Main Authors: Kalra, Sanjay, Sahay, Rakesh, Gupta, Yashdeep
Format: Artigo
Jezik:Inglês
Izdano: Medknow Publications & Media Pvt Ltd 2015
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4481661/
https://ncbi.nlm.nih.gov/pubmed/26180770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.157859
Oznake: Označite
Brez oznak, prvi označite!